SQUAWK/NEWS
Menu
Live News REGULATION L impact

BDRX Biodexa Pharmaceuticals - files for resale of 2.56M adss by selling shareholders - SEC filing

BDRX Biodexa Pharmaceuticals - files for resale of 2.56M adss by selling shareholders - SEC filing

BDRX

BDRX Biodexa Pharmaceuticals - files for resale of 2.56M adss by selling shareholders - SEC filing